<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>465</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15093539</PubmedId>
            <Abstract>We have determined the 3.2 A X-ray crystal structure of the extracellular domain of the human epidermal growth factor receptor 2 (ErbB2 or HER2) in a complex with the antigen binding fragment of pertuzumab, an anti-ErbB2 monoclonal antibody also known as 2C4 or Omnitarg. Pertuzumab binds to ErbB2 near the center of domain II, sterically blocking a binding pocket necessary for receptor dimerization and signaling. The ErbB2-pertuzumab structure, combined with earlier mutagenesis data, defines the pertuzumab residues essential for ErbB2 interaction. To analyze the ErbB2 side of the interface, we have mutated a number of residues contacting pertuzumab and examined the effects of these mutations on pertuzumab binding and ErbB2-ErbB3 heterodimerization. We have also shown that conserved residues previously shown to be necessary for EGF receptor homodimerization may be dispensible for ErbB2-ErbB3 heterodimerization.</Abstract>
            <ArticleYear>2004</ArticleYear>
            <ArticlePages>317-28</ArticlePages>
            <ArticleTitle>Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Franklin</LastName>
                    <ForeName>Matthew C</ForeName>
                </Author>
                <Author>
                    <LastName>Carey</LastName>
                    <ForeName>Kendall D</ForeName>
                </Author>
                <Author>
                    <LastName>Vajdos</LastName>
                    <ForeName>Felix F</ForeName>
                </Author>
                <Author>
                    <LastName>Leahy</LastName>
                    <ForeName>Daniel J</ForeName>
                </Author>
                <Author>
                    <LastName>de Vos</LastName>
                    <ForeName>Abraham M</ForeName>
                </Author>
                <Author>
                    <LastName>Sliwkowski</LastName>
                    <ForeName>Mark X</ForeName>
                </Author>
            </Authors>
            <Affiliations>Department of Protein Engineering, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94114 USA.</Affiliations>
            <ArticleChemicalList>Antibodies, Monoclonal;Antibodies, Monoclonal, Humanized;Ligands;Receptor, ErbB-2;pertuzumab</ArticleChemicalList>
            <ArticleMeshHeadingsList>Animals; Antibodies, Monoclonal(chemistry; genetics; metabolism); Antibodies, Monoclonal, Humanized; Binding Sites; Binding Sites, Antibody; CHO Cells; Cricetinae; Crystallography, X-Ray; Dimerization; Humans; Ligands; Models, Molecular; Mutagenesis, Site-Directed; Protein Structure, Tertiary; Receptor, ErbB-2(chemistry; genetics; metabolism); Signal Transduction</ArticleMeshHeadingsList>
            <Comments>15093533  Cancer Cell. 2004 Apr;5(4):299-301</Comments>
            <Journal>
                <Volume>5</Volume>
                <Issue>4</Issue>
                <Title>Cancer cell</Title>
                <Issn>1878-3686</Issn>
                <MedlineTa>Cancer Cell</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>Epitope of pertuzumab Fab on ErbB2</EpitopeName>
                <EpitopeStructure>
                    <DiscontinuousRegionOnAccessionSequenceMolecule>
                        <ChemicalType>Discontinuous protein residues</ChemicalType>
                        <DiscontinuousResidues>Q178, H267, F279, T290, V308, S310, T312, P316, L317, H318, K333, P337</DiscontinuousResidues>
                        <SourceMolecule>
                            <GenBankId>P04626.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </DiscontinuousRegionOnAccessionSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 5A</LocationOfData>
                <EpitopeId>114178</EpitopeId>
                <ReferenceRegion>Q156, H245, F257, T268, V286, S288, T290, P294, L295, H296, K311, P315</ReferenceRegion>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <BCellId>2020611</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P04626.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The details of the immunization procedure for production of the parent murine anti-ErbB2 monoclonal antibody 2C4 are not published, as stated in the reference: Vajdos et al. (2002) J Mol Biol 320(2): 415-428 [PMID: 12079396]. The antibody was humanized to generate pertuzumab.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope-specific pertuzumab Fab bound to ErbB2 in ELISA. Single alanine substitutions H245, V286, S288, L295, H296, or K311 significantly reduces pertuzumab Fab binding affinity for ErbB2. Double mutations S288A/H296A, L295P/H296N or L295A/H296A abrogated antibody binding.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Antibody construct</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Fab</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>pertuzumab</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG1</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                            <AssayedAntibodyObject>
                                <MultiChainMolecule>
                                    <ChemicalType>Multi-Chain protein</ChemicalType>
                                    <MoleculeName>pertuzumab</MoleculeName>
                                    <Chain1>
                                        <Molecule>
                                            <GenBankId>1S78_D</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain1>
                                    <Chain2>
                                        <Molecule>
                                            <GenBankId>1S78_C</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain2>
                                </MultiChainMolecule>
                            </AssayedAntibodyObject>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>ErbB2</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>P04626.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 4 and Supplementary Figure 1</LocationOfData>
                        <BCellId>2020612</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P04626.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The details of the immunization procedure for production of the parent murine anti-ErbB2 monoclonal antibody 2C4 are not published, as stated in the reference: Vajdos et al. (2002) J Mol Biol 320(2): 415-428 [PMID: 12079396]. The antibody was humanized to generate pertuzumab.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>316</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope-specific pertuzumab antibody blocks heregulin (HRG)-dependent activation of ErbB2-transfected COS-7 cells, as assayed by HRG-dependent ErbB2 phosphorylation.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Antibody construct</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Fab</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>pertuzumab</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG1</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                            <AssayedAntibodyObject>
                                <MultiChainMolecule>
                                    <ChemicalType>Multi-Chain protein</ChemicalType>
                                    <MoleculeName>pertuzumab</MoleculeName>
                                    <Chain1>
                                        <Molecule>
                                            <GenBankId>1S78_D</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain1>
                                    <Chain2>
                                        <Molecule>
                                            <GenBankId>1S78_C</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain2>
                                </MultiChainMolecule>
                            </AssayedAntibodyObject>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>ErbB2</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>P04626.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                            <AntigenContainingObject>
                                <TransfectedCell>
                                    <SubType>Transfected Cell</SubType>
                                    <CellType>Fibroblast</CellType>
                                    <CellSourceOrganismId>9534</CellSourceOrganismId>
                                </TransfectedCell>
                            </AntigenContainingObject>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figures 1, 2, 5, Table 1 and PDB 1S78</LocationOfData>
                        <BCellId>1510569</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P04626.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The details of the immunization procedure for production of the parent murine anti-ErbB2 monoclonal antibody 2C4 are not published, as stated in the reference: Vajdos et al. (2002) J Mol Biol 320(2): 415-428 [PMID: 12079396]. The antibody was humanized to generate pertuzumab.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>436</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>3.25</QuantitativeMeasurement>
                            <MeasurementInequality>=</MeasurementInequality>
                            <AssayComments>The epitope of the Fab fragment of the anti-ErbB2 monoclonal antibody pertuzumab on the soluble extracellular domain of ErbB2 was determined from the crystal structure of the complex, solved by molecular replacement. There are two complexes in the asymmetric unit of the crystal, related by a non-crystallographic 2-fold axis next to residue 162 in domain I of the antigen; this domain I-domain I interaction of two antigen monomers is probably not biologically relevant. The complex comprised of chains B, E, and F is better ordered in the electron density than the other complex.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Antibody construct</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Fab</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>pertuzumab</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG1</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                            <AssayedAntibodyObject>
                                <MultiChainMolecule>
                                    <ChemicalType>Multi-Chain protein</ChemicalType>
                                    <MoleculeName>pertuzumab</MoleculeName>
                                    <Chain1>
                                        <Molecule>
                                            <GenBankId>1S78_D</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain1>
                                    <Chain2>
                                        <Molecule>
                                            <GenBankId>1S78_C</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain2>
                                </MultiChainMolecule>
                            </AssayedAntibodyObject>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>ErbB2 (Her2) extracellular domain</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Fragment of Source Antigen</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TQVCTGTDMKLRLPASPETHLDMLRHLYQGCQVVQGNLELTYLPTNASLSFLQDIQEVQGYVLIAHNQVRQVPLQRLRIVRGTQLFEDNYALAVLDNGDPLNNTTPVTGASPGGLRELQLRSLTEILKGGVLIQRNPQLCYQDTILWKDIFHKNNQLALTLIDTNRSRACHPCSPMCKGSRCWGESSEDCQSLTRTVCAGGCARCKGPLPTDCCHEQCAAGCTGPKHSDCLACLHFNHSGICELHCPALVTYNTDTFESMPNPEGRYTFGASCVTACPYNYLSTDVGSCTLVCPLHNQEVTAEDGTQRCEKCSKPCARVCYGLGMEHLREVRAVTSANIQEFAGCKKIFGSLAFLPESFDGDPASNTAPLQPEQLQVFETLEEITGYLYISAWPDSLPDLSVFQNLQVIRGRILHNGAYSLTLQGLGISWLGLRSLRELGSGLALIHHNTHLCFVHTVPWDQLFRNPHQALLHTANRPEDECVGEGLACHQLCARGHCWGPGPTQCVNCSQFLRGQECVEECRVLQGLPREYVNARHCLPCHPECQPQNGSVTCFGPEADQCVACAHYKDPPFCVARCPSGVKPDLSYMPIWKFPDEEGACQPCPINCTHSCVDLDDKGCPAEQ</LinearSequence>
                                        <StartingPosition>23</StartingPosition>
                                        <EndingPosition>646</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P04626.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <ThreeDimensionalStructureOfComplex>
                            <ComplexPdbId>1S78</ComplexPdbId>
                            <AntibodyChain1PdbChain>F</AntibodyChain1PdbChain>
                            <AntibodyChain2PdbChain>E</AntibodyChain2PdbChain>
                            <AntigenChainPdbChain>B</AntigenChainPdbChain>
                            <ViewerFlag>Y</ViewerFlag>
                            <Comments>The epitope is located near the junction of domains I, II, and III of the antigen, with contact area in domain II of 1147 Å² and domain I only 63 Å². However, the conformation of the dimerization hairpin as well as the whole antigen in Fab bound form are similar to those seen in the free antigen [PDB: 1N8Y] and in complex with antibody trastuzumab [PDB: 1N8Z].</Comments>
                            <CuratedContacts>
                                <EpitopeResidues>B: Q156, H245, F257, T268, V286, S288, T290, P294, L295, H296, K311, P315</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>F: ; E: ;</AntibodyResiduesInteractingWithAntigen>
                                <ContactAreaForAntigen>1210.0</ContactAreaForAntigen>
                                <ContactAreaForAntibody>1114.0</ContactAreaForAntibody>
                            </CuratedContacts>
                            <CalculatedContacts>
                                <EpitopeResidues>B: K128, Q156, F236, H245, C246, A248, Y252, T254, D255, T256, F257, T268, V286, G287, S288, T290, V292, P294, L295, H296, K311, K314, P315</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>E: Y49, Y53, Y55, Y94; F: T30, D31, Y32, T33, N52, N53, S54, G55, S57, I58, Y59, Q61, K64, V71, R73, S74, K75, R94, L96, G97, P98, S99, Y99B, D101</AntibodyResiduesInteractingWithAntigen>
                                <ContactAreaForAntigen>1179.8</ContactAreaForAntigen>
                                <ContactAreaForAntibody>1065.1</ContactAreaForAntibody>
                            </CalculatedContacts>
                        </ThreeDimensionalStructureOfComplex>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

